More on KYMR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-31.9% Growth)
- Ratings (8.7 Score)
- Holders

Upcoming Events

- Earnings (10/29/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Kymera Therapeutics (NQ:KYMR)
Delayed: 119.30 +0.25 (0.21%)
Prev. Close $119.05  
Open$119.58 
52 Wk High$ 
52 Wk Low$ 
Day High$123.54 
Day Low$117.42 
P/E N/A  
EPS$ 
Volume619,871 

Friends, Peers and Foes (?): ASND, BIIB, DYN, GILD, XENE (more...)

Sep 2, 2026 09:22 AM Kymera Therapeutics (KYMR) PT Raised to $140 at JPMorgan
Aug 31, 2026 07:09 AM Kymera Therapeutics (KYMR) PT Raised to $170 at Guggenheim
Aug 27, 2026 07:14 AM Kymera Therapeutics (KYMR) PT Raised to $151 at Wells Fargo
Aug 22, 2026 07:54 AM TD Cowen Assumes Kymera Therapeutics (KYMR) at Buy
Aug 14, 2026 10:39 AM Form SCHEDULE 13G/A Kymera Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Aug 13, 2026 04:43 PM Form SCHEDULE 13G/A Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Aug 6, 2026 08:52 AM Kymera Therapeutics (KYMR) PT Raised to $135 at Morgan Stanley
Aug 6, 2026 04:19 AM Kymera Therapeutics (KYMR) PT Raised to $139 at Barclays
Aug 5, 2026 02:56 PM Kymera Therapeutics (KYMR) PT Raised to $125 at Oppenheimer
Aug 5, 2026 10:42 AM Kymera Therapeutics (KYMR) PT Raised to $132 at Stifel
View All Articles

Entities mentioned with KYMR

View All Entities